These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 20966598)

  • 1. Expression of chemokines, CXC chemokine ligand 10 (CXCL10) and CXCR3 in the inflamed islets of patients with recent-onset autoimmune type 1 diabetes.
    Uno S; Imagawa A; Saisho K; Okita K; Iwahashi H; Hanafusa T; Shimomura I
    Endocr J; 2010; 57(11):991-6. PubMed ID: 20966598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enterovirus infection, CXC chemokine ligand 10 (CXCL10), and CXCR3 circuit: a mechanism of accelerated beta-cell failure in fulminant type 1 diabetes.
    Tanaka S; Nishida Y; Aida K; Maruyama T; Shimada A; Suzuki M; Shimura H; Takizawa S; Takahashi M; Akiyama D; Arai-Yamashita S; Furuya F; Kawaguchi A; Kaneshige M; Katoh R; Endo T; Kobayashi T
    Diabetes; 2009 Oct; 58(10):2285-91. PubMed ID: 19641142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXC chemokine ligand 10 neutralization suppresses the occurrence of diabetes in nonobese diabetic mice through enhanced beta cell proliferation without affecting insulitis.
    Morimoto J; Yoneyama H; Shimada A; Shigihara T; Yamada S; Oikawa Y; Matsushima K; Saruta T; Narumi S
    J Immunol; 2004 Dec; 173(11):7017-24. PubMed ID: 15557199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Th1-Like ICOS+ Foxp3+ Treg Cells Preferentially Express CXCR3 and Home to β-Islets during Pre-Diabetes in BDC2.5 NOD Mice.
    Kornete M; Mason ES; Girouard J; Lafferty EI; Qureshi S; Piccirillo CA
    PLoS One; 2015; 10(5):e0126311. PubMed ID: 25946021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional redundancy of CXCR3/CXCL10 signaling in the recruitment of diabetogenic cytotoxic T lymphocytes to pancreatic islets in a virally induced autoimmune diabetes model.
    Coppieters KT; Amirian N; Pagni PP; Baca Jones C; Wiberg A; Lasch S; Hintermann E; Christen U; von Herrath MG
    Diabetes; 2013 Jul; 62(7):2492-9. PubMed ID: 23434930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Islet inflammation and CXCL10 in recent-onset type 1 diabetes.
    Roep BO; Kleijwegt FS; van Halteren AG; Bonato V; Boggi U; Vendrame F; Marchetti P; Dotta F
    Clin Exp Immunol; 2010 Mar; 159(3):338-43. PubMed ID: 20059481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of CXCL10 receptor antagonist on islet cell apoptosis in a type I diabetes rat model.
    He J; Lian C; Fang Y; Wu J; Weng J; Ye X; Zhou H
    Int J Clin Exp Pathol; 2015; 8(11):14542-8. PubMed ID: 26823775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut dysbiosis promotes islet-autoimmunity by increasing T-cell attraction in islets via CXCL10 chemokine.
    Pöysti S; Silojärvi S; Brodnicki TC; Catterall T; Liu X; Mackin L; Luster AD; Kay TWH; Christen U; Thomas HE; Hänninen A
    J Autoimmun; 2023 Nov; 140():103090. PubMed ID: 37572540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Among CXCR3 chemokines, IFN-gamma-inducible protein of 10 kDa (CXC chemokine ligand (CXCL) 10) but not monokine induced by IFN-gamma (CXCL9) imprints a pattern for the subsequent development of autoimmune disease.
    Christen U; McGavern DB; Luster AD; von Herrath MG; Oldstone MB
    J Immunol; 2003 Dec; 171(12):6838-45. PubMed ID: 14662890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic deletion of chemokine receptor CXCR3 or antibody blockade of its ligand IP-10 modulates posttransplantation graft-site lymphocytic infiltrates and prolongs functional graft survival in pancreatic islet allograft recipients.
    Baker MS; Chen X; Rotramel AR; Nelson JJ; Lu B; Gerard C; Kanwar Y; Kaufman DB
    Surgery; 2003 Aug; 134(2):126-33. PubMed ID: 12947308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis.
    Frigerio S; Junt T; Lu B; Gerard C; Zumsteg U; Holländer GA; Piali L
    Nat Med; 2002 Dec; 8(12):1414-20. PubMed ID: 12415259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCL10 activities, biological structure, and source along with its significant role played in pathophysiology of type I diabetes mellitus.
    Ahmadi Z; Arababadi MK; Hassanshahi G
    Inflammation; 2013 Apr; 36(2):364-71. PubMed ID: 23065240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCR3, CXCL10 and type 1 diabetes.
    Antonelli A; Ferrari SM; Corrado A; Ferrannini E; Fallahi P
    Cytokine Growth Factor Rev; 2014 Feb; 25(1):57-65. PubMed ID: 24529741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic Alpha-Cells Contribute Together With Beta-Cells to CXCL10 Expression in Type 1 Diabetes.
    Nigi L; Brusco N; Grieco GE; Licata G; Krogvold L; Marselli L; Gysemans C; Overbergh L; Marchetti P; Mathieu C; Dahl Jørgensen K; Sebastiani G; Dotta F
    Front Endocrinol (Lausanne); 2020; 11():630. PubMed ID: 33042009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small molecule CXCR3 antagonist NIBR2130 has only a limited impact on type 1 diabetes in a virus-induced mouse model.
    Christen S; Holdener M; Beerli C; Thoma G; Bayer M; Pfeilschifter JM; Hintermann E; Zerwes HG; Christen U
    Clin Exp Immunol; 2011 Sep; 165(3):318-28. PubMed ID: 21649647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unique Inflammatory Changes in Exocrine and Endocrine Pancreas in Enterovirus-Induced Fulminant Type 1 Diabetes.
    Takita M; Jimbo E; Fukui T; Aida K; Shimada A; Oikawa Y; Yagihashi S; Miura J; Babazono T; Kobayashi T
    J Clin Endocrinol Metab; 2019 Oct; 104(10):4282-4294. PubMed ID: 31112279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Islet-Expressed CXCL10 Promotes Autoimmune Destruction of Islet Isografts in Mice With Type 1 Diabetes.
    Bender C; Christen S; Scholich K; Bayer M; Pfeilschifter JM; Hintermann E; Christen U
    Diabetes; 2017 Jan; 66(1):113-126. PubMed ID: 27797910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acceleration of diabetes development in CXC chemokine receptor 3 (CXCR3)-deficient NOD mice.
    Yamada Y; Okubo Y; Shimada A; Oikawa Y; Yamada S; Narumi S; Matsushima K; Itoh H
    Diabetologia; 2012 Aug; 55(8):2238-45. PubMed ID: 22487925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of interferon-gamma- inducible protein-10 and its receptor CXCR3 in chronic pancreatitis.
    Singh L; Bakshi DK; Majumdar S; Vasishta RK; Arora SK; Wig JD
    Pancreatology; 2007; 7(5-6):479-90. PubMed ID: 17912012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokines as Drivers of the Autoimmune Destruction in Type 1 Diabetes: Opportunity for Therapeutic Intervention in Consideration of an Optimal Treatment Schedule.
    Christen U; Kimmel R
    Front Endocrinol (Lausanne); 2020; 11():591083. PubMed ID: 33193102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.